---
source: scan desk handoff 2026-10-23 (job 0a12065e50); no /raw doc
created: 2026-10-23
updated: 2026-10-23
tags: [trade-verdict, debate, no-trade]
---

# Trade Verdict - 2026-10-23

**Verdict:** No trade today. Conviction 4/5.

## Candidates (scan desk job 0a12065e50)
JNJ (TB), VRTX (TB), EMR (WS), LTC (both), REGN (WS), LQDT (both), CENTA (both, +8.1% vs 50d). No pending cash deals (research analyst). Scan prices were Oct 22 closes.

## Evidence
- Quant: best JNJ (p 0.38, EV +0.14R, CI -0.17 to +0.48), LQDT EV +0.17R but earnings Nov 19 inside hold; VRTX EV -0.04R. All CIs include 0. Log: quant-debate-2026-10-23.md
- Backtester: JNJ best own-history (n=25, +1.79 shrunk OOS) but in-sample negative and signal not firing (last 9/24). LQDT n=1 and WS last fired 7/31, so not a same-week both entry. LTC veto (0/5 beat SPY). VRTX, EMR, REGN negative. Note: bt-2026-10-23-debate-candidates.md
- Research: picked VRTX, then withdrew it in rebuttal; leans JNJ (talc headline risk). LQDT 41x P/E into Nov 19 print.

## Bear side
Backtester (assigned): no candidate has a firing, same-week both-signal setup with its own record; cash beats a CI crossing zero.

## Strongest for
JNJ: best since-2022 history, raised guidance, no earnings until Jan 26.

## Strongest against
No live tested signal; JNJ honest EV ~0 (quant).

## Dissent
Quant and research lean JNJ if anything is taken: entry 263.64, stop 250.76, target 289.40, half size ~38 shares per $100k.

## Outcome check (due 2026-10-30)
JNJ from 263.64 (stop 250.76 / target 289.40); LQDT 44.30 (42.19 / 48.51).

## Correction (2026-10-27)
The pooled both-signals edge (+0.38% vs SPY) cited in earlier verdicts was a lookahead artifact (about +0.7pp premium). Backtester's lookahead-free rerun (OOS 2022-26, n~4,000, vs SPY): T20 -0.23% (CI -0.86 to +0.43), STATE_TB -0.32%, STATE_WS -0.90%. Both minus WS-only on T20 is +0.13pp (CI -0.32 to +0.60), not different from zero. There is no both-signals edge. This verdict was no-trade, so the conclusion stands. See bt-2026-10-27-both-lookahead-free.md.
